News
ctDNA, CTCs predict TNBC relapse – now what?
- Author:
- Neil Osterweil
SAN ANTONIO – Liquid biopsy can identify patients with triple-negative breast cancer at high risk of relapse, but no...
News
Pembrolizumab plus chemo boosts pCR rate in TNBC
- Author:
- Neil Osterweil
SAN ANTONIO – The immune checkpoint inhibitor added to standard chemotherapy increased the likelihood of a pathologic complete remission,...
News
Sutimlimab boosts hemoglobin, quality of life in cold agglutinin disease
- Author:
- Neil Osterweil
ORLANDO – A novel antibody targeted to the complement pathway increased hemoglobin and improved quality of life in patients with cold agglutinin...
News
Trastuzumab deruxtecan has good activity in advanced HER2-positive breast cancer
- Author:
- Neil Osterweil
SAN ANTONIO – The overall response rate was 61% in heavily pretreated patients, but interstitial lung disease was a major side effect of the...
News
Failed ATEMPT: T-DM1 no safer in early HER2+ breast cancer
- Author:
- Neil Osterweil
SAN ANTONIO – The incidence of clinically relevant toxicity was similar between trastuzumab emtansine and...
News
Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCL
- Author:
- Neil Osterweil
ORLANDO – Despite modest efficacy, response durations, progression-free survival, and overall survival were...
News
Care coordination, equity can eliminate disparities for nonwhite patients with DLBCL
- Author:
- Neil Osterweil
The use of a nurse navigation program to facilitate care helped iron out racial disparities that could lead to poor outcomes.
News
High complete response rate seen with novel CAR-T for myeloma
- Author:
- Neil Osterweil
ORLANDO – A CAR T product targeting B-cell maturation antigen, one of several in development, was associated with a 100% overall response rate.
News
Bilateral mastectomy reduces second breast cancer risk, but not deaths
- Author:
- Neil Osterweil
The risk of second contralateral breast cancer is low regardless of primary breast cancer therapy, results of a retrospective study show.
News
Survival gains in HR+/HER2– MBC trials yet to be seen in real world
- Author:
- Neil Osterweil
The introduction of nine new systemic adjuvant therapies did not change survival outcomes for patients with HR+/HER2- metastatic breast cancer.
News
Single-fraction radiation just misses mark for spinal compression relief
- Author:
- Neil Osterweil
The primary noninferiority endpoint was not met, but a small difference between single- and multi-fraction radiation may not be clinically...
News
Transfusion-related lung injury is on the rise in elderly patients
- Author:
- Neil Osterweil
SAN ANTONIO – Researchers at the Food and Drug Administration examined trends in potentially life-threatening or fatal transfusion-related adverse...
News
Cancer pain management inadequate in opioid-saturated areas
- Author:
- Neil Osterweil
Less than one-fourth of cancer patients in rural southwest Virginia received prescription opioids, suggesting suboptimal pain management.
News
Getting high heightens stroke, arrhythmia risks
- Author:
- Neil Osterweil
Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies.
News
Best practice alerts really can work
- Author:
- Neil Osterweil
SAN ANTONIO – A majority of alerts triggered by red blood cell orders were overridden, but for sound clinical reasons, investigators found.